NeoPharm CO., LTD. (KOSDAQ:092730)

Market Cap	288.89B
Revenue (ttm)	129.81B
Net Income (ttm)	27.80B
Shares Out	15.64M
EPS (ttm)	1,777.18
PE Ratio	10.39
Forward PE	11.00
Dividend	600.00 (3.25%)
Ex-Dividend Date	Dec 29, 2025

Volume	37,093
Average Volume	83,143
Open	18,470
Previous Close	18,470
Day's Range	18,270 - 18,650
52-Week Range	10,700 - 22,650
Beta	0.57
RSI	41.31
Earnings Date	Feb 6, 2026

About NeoPharm CO., LTD.

NeoPharm CO., LTD. engages in the manufacturing and sale of skin care products in South Korea. The company provides Atopalm, a non-steroid product for sensitive and dry skin; skin dermo-cosmetic products under the Real Barrier brand name; sensitive, dry, oily, or trouble-prone skin care products under the ZEROID brand; body moisturizers under the Derma-B brand name; sport care products under the MISSION ATHELETCARE brand; and dermArtlogy, a 1:1 consulting cosmetic brand. NeoPharm CO., LTD. was founded in 2000 and is headquartered in Daejeon, So...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 2000
• Employees: 82
• Stock Exchange: KOSDAQ
• Ticker Symbol: 092730

Financial Performance

In 2024, NeoPharm CO., LTD.'s revenue was 119.01 billion, an increase of 22.56% compared to the previous year's 97.10 billion. Earnings were 23.06 billion, a decrease of -0.64%.